Cargando…

Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients

Detalles Bibliográficos
Autores principales:	Al-Hubail, R, Hassan, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363838/ http://dx.doi.org/10.1186/cc11027

Ejemplares similares

Prevalence and incidence of proximal deep vein thrombosis in critically ill patients
por: Panitchote, A, et al.
Publicado: (2010)

Enoxaparin sodium: Lack of efficacy in deep vein thrombosis prophylaxis: 3 case reports
Publicado: (2020)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

Anti-activated factor × response to enoxaparin in critically ill patients
por: Einav, S, et al.
Publicado: (2009)

Incidence and outcome of asymptomatic deep vein thrombosis in critically ill patients: a prospective cohort study
por: Echigoya, R, et al.
Publicado: (2015)

Incidence of deep vein thrombosis in critically ill ICU patients with a femoral central venous catheter
por: Myrianthefs, P, et al.
Publicado: (2004)

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
por: Çiçek, Necati, et al.
Publicado: (2021)

Deep venous thrombosis Doppler screening in critically ill patients: is it justified?
por: Vlachou, I, et al.
Publicado: (2011)

Proximal and distal deep venous thrombosis in critically ill patients: incidence and prevalence
por: Yus Teruel, S, et al.
Publicado: (2012)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

The journey to zero deep-vein thrombosis in critically ill patients
por: Arabi, Yaseen M., et al.
Publicado: (2019)

Evaluation of deep vein thrombosis in patients with severe traumatic brain injuries
por: Mendez, P, et al.
Publicado: (2015)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Multi-sequence non-contrast MRI characterization of deep vein thrombosis in man
por: Phinikaridou, Alkystis, et al.
Publicado: (2015)

Multidrug sedation as a risk factor for deep vein thrombosis in the intensive care unit
por: Barbani, F, et al.
Publicado: (2010)

Deep Vein Thrombosis Prophylaxis in Trauma Patients
por: Toker, Serdar, et al.
Publicado: (2011)

Effective dosage of enoxaparin for intensive care patients
por: Robinson, S, et al.
Publicado: (2013)

Safety and efficacy of amphotericin B inhalation for Candida spp. in the respiratory tract of critically ill patients
por: Van der Geest, P, et al.
Publicado: (2014)

Compression ultrasonography training program for ICU physicians does improve deep vein thrombosis risk management
por: Cecchi, A, et al.
Publicado: (2009)

Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019)

Prophylaxis and Incidence of Symptomatic Deep Vein Thrombosis in Indian Patients with Sepsis: DETECT-Deep Vein Thrombosis Registry
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2017)

Clinical signs and risk factors of acute deep vein thrombosis of lower extremities in patients after abdominal surgery for cancer: efficiency and safety of different types of anticoagulant therapy
por: Tarabrin, O, et al.
Publicado: (2010)

Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient
por: Samson, AD, et al.
Publicado: (2009)

Prothrombin gene and factor V Leiden gene polymorphism in patients with deep vein thrombosis: prevalence, diagnostic and therapeutic implications
por: Rizk, A, et al.
Publicado: (2006)

Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China
por: Yang, Li, et al.
Publicado: (2020)

A Pilot Study of Home Treatment of Deep Vein Thrombosis With Subcutaneous Once-Daily Enoxaparin Plus Warfarin
por: Bishop, Beverly, et al.
Publicado: (2006)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Evaluation of deep vein thrombosis prophylaxis in a general hospital
por: Farhat, Fátima Cristiane Lopes Goularte, et al.
Publicado: (2018)

Efficacy of a palliative care program in critically ill patients
por: Ribeiro, SCF, et al.
Publicado: (2011)

Safety and efficacy of low-molecular-weight heparins in prophylaxis of deep vein thrombosis in postoperative/ICU patients: A comparative study
por: Saxena, Arpita, et al.
Publicado: (2013)

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021)

Prophylaxis of thromboembolic disease: patient safety protocoL
por: Viejo Moreno, R, et al.
Publicado: (2015)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

The conundrum of deep vein thrombosis prophylaxis in burns in India and review of literature
por: Shirol, S. S., et al.
Publicado: (2017)

Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
por: Todorova, VT, et al.
Publicado: (2013)

Efficacy of electrical muscle stimulation on preserving the muscle mass of critically ill patients
por: Gerovasili, V, et al.
Publicado: (2008)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

Retrospective analysis of the efficacy of radio-contrast-induced nephropathy prophylaxis
por: Wood, J, et al.
Publicado: (2015)

Safety of semi-open percutaneous tracheotomy when performed in critically ill burn patients
por: Gerold, K, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_2aqpmomvfi6miin9p6rmettjeu